PubRank

Nirbhay Kumar

Author PubWeight™ 66.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005 3.85
2 Detection of Plasmodium falciparum in pregnancy by laser desorption mass spectrometry. Am J Trop Med Hyg 2005 1.81
3 A filter paper method for the detection of Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Am J Trop Med Hyg 2008 1.54
4 Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J Trop Med Hyg 2004 1.54
5 Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice. Vaccine 2010 1.54
6 A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli. PLoS One 2009 1.51
7 Genome annotation of Anopheles gambiae using mass spectrometry-derived data. BMC Genomics 2005 1.51
8 Malaria parasite invasion of the mosquito salivary gland requires interaction between the Plasmodium TRAP and the Anopheles saglin proteins. PLoS Pathog 2009 1.44
9 Knowledge attitudes and practices of grade three primary schoolchildren in relation to schistosomiasis, soil transmitted helminthiasis and malaria in Zimbabwe. BMC Infect Dis 2011 1.21
10 Aquaporin 9 is the major pathway for glycerol uptake by mouse erythrocytes, with implications for malarial virulence. Proc Natl Acad Sci U S A 2007 1.18
11 Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection. Infect Immun 2006 1.15
12 A proteogenomic analysis of Anopheles gambiae using high-resolution Fourier transform mass spectrometry. Genome Res 2011 1.14
13 Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect Immun 2004 1.14
14 Aquaglyceroporin PbAQP during intraerythrocytic development of the malaria parasite Plasmodium berghei. Proc Natl Acad Sci U S A 2007 1.13
15 Purified malaria pigment (hemozoin) enhances dendritic cell maturation and modulates the isotype of antibodies induced by a DNA vaccine. Infect Immun 2002 1.13
16 Infection with parasitic nematodes confounds vaccination efficacy. Vet Parasitol 2007 1.10
17 Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis 2015 1.06
18 A proteomic analysis of salivary glands of female Anopheles gambiae mosquito. Proteomics 2005 1.05
19 Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization. Malar J 2009 1.04
20 Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation. Vaccine 2007 1.03
21 Impact of schistosome infection on Plasmodium falciparum Malariometric indices and immune correlates in school age children in Burma Valley, Zimbabwe. PLoS Negl Trop Dis 2010 1.02
22 Structure of a gametocyte protein essential for sexual development in Plasmodium falciparum. Nat Struct Biol 2003 1.01
23 Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Infect Immun 2008 1.01
24 Rapid detection of malaria infection in vivo by laser desorption mass spectrometry. Am J Trop Med Hyg 2004 0.98
25 Molecular players of homologous recombination in protozoan parasites: implications for generating antigenic variation. Infect Genet Evol 2004 0.97
26 Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo. Chem Biol 2009 0.97
27 Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen. Vaccine 2010 0.97
28 Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding. Infect Immun 2014 0.96
29 Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. Vaccine 2004 0.95
30 Phase I/II evaluation of the prophylactic antimalarial activity of pafuramidine in healthy volunteers challenged with Plasmodium falciparum sporozoites. Am J Trop Med Hyg 2009 0.93
31 Exacerbation of Plasmodium yoelii malaria in Echinostoma caproni infected mice and abatement through anthelmintic treatment. J Parasitol 2005 0.92
32 Identification and molecular characterisation of DNA damaging agent induced expression of Plasmodium falciparum recombination protein PfRad51. Int J Parasitol 2003 0.92
33 Centrins, cell cycle regulation proteins in human malaria parasite Plasmodium falciparum. J Biol Chem 2008 0.92
34 Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen. Infect Immun 2004 0.92
35 Critical role of a K+ channel in Plasmodium berghei transmission revealed by targeted gene disruption. Proc Natl Acad Sci U S A 2008 0.92
36 Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific. Infect Immun 2005 0.90
37 Antibody responses to Plasmodium falciparum vaccine candidate antigens in three areas distinct with respect to altitude. Acta Trop 2006 0.90
38 Plasmodium yoelii: adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp Parasitol 2009 0.89
39 Extra terminal residues have a profound effect on the folding and solubility of a Plasmodium falciparum sexual stage-specific protein over-expressed in Escherichia coli. Eur J Biochem 2002 0.88
40 Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons. Vaccine 2013 0.87
41 High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe. Parasitol Res 2007 0.85
42 A modified Plasmodium falciparum growth inhibition assay (GIA) to assess activity of plasma from malaria endemic areas. Exp Parasitol 2006 0.85
43 Enhanced malaria parasite transmission from helminth co-infected mice. Am J Trop Med Hyg 2007 0.84
44 Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors. J Leukoc Biol 2005 0.84
45 Functional analysis of Plasmodium falciparum parasitophorous vacuole membrane protein (Pfs16) during gametocytogenesis and gametogenesis by targeted gene disruption. Mol Biochem Parasitol 2004 0.84
46 Host microsatellite alleles in malaria predisposition? Malar J 2005 0.83
47 Plasmodium falciparum protein phosphatase type 1 functionally complements a glc7 mutant in Saccharomyces cerevisiae. Int J Parasitol 2002 0.83
48 Opposing roles for two molecular forms of replication protein A in Rad51-Rad54-mediated DNA recombination in Plasmodium falciparum. MBio 2013 0.83
49 Counter-regulatory anti-parasite cytokine responses during concurrent Plasmodium yoelii and intestinal helminth infections in mice. Exp Parasitol 2008 0.83
50 Characterization of kinetics of DNA strand-exchange and ATP hydrolysis activities of recombinant PfRad51, a Plasmodium falciparum recombinase. Mol Biochem Parasitol 2005 0.83
51 Antimalarial Preclinical Drug Development: A Single Oral Dose of A 5-Carbon-linked Trioxane Dimer Plus Mefloquine Cures Malaria-Infected Mice. Drug Dev Res 2009 0.82
52 Functional characterisation of sexual stage specific proteins in Plasmodium falciparum. Int J Parasitol 2002 0.81
53 Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines. Eukaryot Cell 2008 0.81
54 A compendium of molecules involved in vector-pathogen interactions pertaining to malaria. Malar J 2013 0.81
55 Translocation of ribosomal protein P0 onto the Toxoplasma gondii tachyzoite surface. Int J Parasitol 2003 0.80
56 A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein. J Immunol Methods 2013 0.80
57 Brain proteomics of Anopheles gambiae. OMICS 2014 0.79
58 Identification of biochemically distinct properties of the small ubiquitin-related modifier (SUMO) conjugation pathway in Plasmodium falciparum. J Biol Chem 2013 0.79
59 Novel nanosomes for gene delivery to Plasmodium falciparum-infected red blood cells. Sci Rep 2013 0.79
60 Aberrant sporogonic development of Dmc1 (a meiotic recombinase) deficient Plasmodium berghei parasites. PLoS One 2012 0.78
61 Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation. J Mol Diagn 2013 0.78
62 Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study. BMC Int Health Hum Rights 2011 0.78
63 Analysis of genetic polymorphism in select vaccine candidate antigens and microsatellite loci in Plasmodium falciparum from endemic areas at varying altitudes. Acta Trop 2007 0.78
64 Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45. Infect Immun 2006 0.77
65 Transdermal Diagnosis of Malaria Using Vapor Nanobubbles. Emerg Infect Dis 2016 0.75
66 Effect of probenecid on kinetics of enrofloxacin in lactating goats after subcutaneous administration. Indian J Exp Biol 2009 0.75
67 Expression, purification, crystallization and preliminary X-ray analysis of the sexual stage-specific protein Pfg27 from Plasmodium falciparum. Acta Crystallogr D Biol Crystallogr 2002 0.75